TABLE 4

Recommended Seasonal Influenza Vaccines for Different Age Groups: United States, 2017–2018 Influenza Season

VaccineTrade NameManufacturerPresentationThimerosal Mercury Content (μg of Hg/0.5-mL dose)Age Group
Inactivated
 IIV3Fluzone high-doseSanofi pasteur0.5-mL prefilled syringe0≥65 y
 IIV3FluvirinSeqirus0.5-mL prefilled syringe≤1.0≥4 y
5.0-mL multidose vial25≥4 y
 IIV3AfluriaSeqirus0.5-mL prefilled syringe0≥5 y
5.0-mL multidose vial24.5≥5 y
 aIIV3FluadSeqirus0.5-mL prefilled syringe0≥65 y
 ccIIV4Flucelvax quadrivalentSeqirus0.5-mL prefilled syringe0≥4 y
5.0-mL multidose vial25≥4 y
 IIV4Fluzone quadrivalentSanofi pasteur0.25-mL prefilled syringe06–35 mo
0.5-mL prefilled syringe0≥36 mo
0.5-mL vial0≥36 mo
5.0-mL multidose vial25≥6 mo
 IIV4Fluzone ID quadrivalentSanofi pasteur0.1-mL prefilled microinjection018–64 y
 IIV4Fluarix quadrivalentGlaxoSmithKline0.5-mL prefilled syringe0≥3 y
 IIV4FluLaval quadrivalentID biomedical corporation of quebec (distributed by GlaxoSmithKline)0.5-mL prefilled syringe0≥6 mo
5.0-mL multidose vial<25≥6 mo
 IIV4Afluria quadrivalentSeqirus0.5-mL prefilled syringe0≥18 y
5.0-mL multidose vial24.5≥18 y
Recombinant
 RIV3FlublokProtein sciences0.5-mL vial0≥18 y
 RIV4Flublok quadrivalentProtein sciences0.5-mL prefilled syringe0≥18 y
  • Data sources: American Academy of Pediatrics, Committee on Infectious Diseases. Recommendations for prevention and control of influenza in children, 2016–2017. Pediatrics. 2016;138(4):e20162527; Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18 influenza aeason. MMWR Recomm Rep. 2017;66(No. RR-2):1–20. Implementation guidance on supply, pricing, payment, current procedural terminology coding, and liability issues can be found at www.aapredbook.org/implementation. ccIIV4, quadrivalent cell culture-based IIV. RIV3, trivalent recombinant influenza vaccine; RIV4, quadrivalent recombinant influenza vaccine.